No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Recent Blog Postings
- Allogene Therapeutics’ ALLO-329 Receives FDA Fast Track Designation for Three Autoimmune Conditions, Including Active Refractory Moderate-to-Severe Systemic Lupus Erythematosus
- Survey Highlights the Significant Impact of Cutaneous Lupus Erythematosus on People’s Lives
- Study Finds Certolizumab Pegol May Improve Pregnancy Outcomes in Women with Lupus and Antiphospholipid Syndrome